Veteran Biotech Communications Execs Launch Opus Biotech Communications, New PR/IR Services for Emerging Biotech and Life Sciences Companies SEATTLE–October 12, 2016 –Two experienced executives, a former Biotechnology Industry Organization Vice President of Communications and a former President of Georgia Bio, announced the formation of Opus Biotech Communications (www.opusbiotech.com) with offices in Seattle and Atlanta. Opus Biotech will offer reputation management, strategic public relations and investor relations services geared toward early-stage companies as well as communication audits and programs for established companies. “Start-up companies are focused on advancing their research,” said Opus Biotech cofounder Dan Eramian, “but unless they can compellingly articulate the value of their unique stories to investors early on, they risk leaving their technology in the lab.” Eramian and cofounder Charles Craig have a combined four decades experience in public relations, investor relations, government affairs and reputation building. “Start-up companies live in a highly competitive environment,” said Craig.
Read more →
Posts Tagged Dan Post
